JP2022551551A5 - - Google Patents

Info

Publication number
JP2022551551A5
JP2022551551A5 JP2022506030A JP2022506030A JP2022551551A5 JP 2022551551 A5 JP2022551551 A5 JP 2022551551A5 JP 2022506030 A JP2022506030 A JP 2022506030A JP 2022506030 A JP2022506030 A JP 2022506030A JP 2022551551 A5 JP2022551551 A5 JP 2022551551A5
Authority
JP
Japan
Prior art keywords
syndrome
disease
sample
item
variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022506030A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022551551A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/055293 external-priority patent/WO2021072394A1/en
Publication of JP2022551551A publication Critical patent/JP2022551551A/ja
Publication of JP2022551551A5 publication Critical patent/JP2022551551A5/ja
Pending legal-status Critical Current

Links

JP2022506030A 2019-10-11 2020-10-12 ロングリードシークエンシングを用いたゲノム構造バリアントの同定 Pending JP2022551551A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962913886P 2019-10-11 2019-10-11
US62/913,886 2019-10-11
US202062981146P 2020-02-25 2020-02-25
US62/981,146 2020-02-25
PCT/US2020/055293 WO2021072394A1 (en) 2019-10-11 2020-10-12 Identification of genomic structural variants using long-read sequencing

Publications (2)

Publication Number Publication Date
JP2022551551A JP2022551551A (ja) 2022-12-12
JP2022551551A5 true JP2022551551A5 (https=) 2023-10-19

Family

ID=75436767

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022506030A Pending JP2022551551A (ja) 2019-10-11 2020-10-12 ロングリードシークエンシングを用いたゲノム構造バリアントの同定

Country Status (5)

Country Link
US (1) US20230028445A1 (https=)
EP (1) EP4041916A4 (https=)
JP (1) JP2022551551A (https=)
CN (1) CN114555824A (https=)
WO (1) WO2021072394A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114752668B (zh) * 2022-05-13 2025-08-01 深圳市优圣康生物科技有限公司 Crispr、cas9靶向捕获长片段dna的贫血筛查试剂盒及其方法
CN115232866A (zh) * 2022-08-08 2022-10-25 南方医科大学皮肤病医院(广东省皮肤病医院、广东省皮肤性病防治中心、中国麻风防治研究中心) 一种基于纳米孔测序靶向富集细菌16S rRNA基因的测序方法
WO2025049355A1 (en) * 2023-08-26 2025-03-06 Duke University Compositions comprising nanoparticles for targeted delivery and methods of using the same
WO2025235828A2 (en) * 2024-05-08 2025-11-13 The General Hospital Corporation Engineered prime editors for treating genetic deafness
CN119662814B (zh) * 2025-02-20 2025-06-27 北京贝瑞和康生物技术有限公司 检测戈谢病gba1基因及其假基因gbap1多种突变的引物组、试剂盒及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3633047B1 (en) * 2014-08-19 2022-12-28 Pacific Biosciences of California, Inc. Method of sequencing nucleic acids based on an enrichment of nucleic acids
BR112017008877A2 (pt) * 2014-10-29 2018-07-03 10X Genomics Inc métodos e composições para sequenciamento de ácido nucleico-alvo
CN107250445A (zh) * 2015-02-27 2017-10-13 富鲁达公司 用于高通量研究的单个细胞核酸
KR102888521B1 (ko) * 2015-04-06 2025-11-19 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 Crispr/cas-매개 유전자 조절을 위한 화학적으로 변형된 가이드 rna

Similar Documents

Publication Publication Date Title
JP2022551551A5 (https=)
Kim et al. Unbiased investigation of specificities of prime editing systems in human cells
Cao et al. Nick-seq for single-nucleotide resolution genomic maps of DNA modifications and damage
Haile et al. Sources of erroneous sequences and artifact chimeric reads in next generation sequencing of genomic DNA from formalin-fixed paraffin-embedded samples
Shin et al. Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9
Cromwell et al. Incorporation of bridged nucleic acids into CRISPR RNAs improves Cas9 endonuclease specificity
CN107002118B (zh) 用于无细胞dna的定量遗传分析的方法
Van Dijk et al. Library preparation methods for next-generation sequencing: tone down the bias
EP3158066B1 (en) Genomewide unbiased identification of dsbs evaluated by sequencing (guide-seq)
US20210189466A1 (en) Profiling Expression at Transcriptome Scale
Tsai et al. Amplification-free, CRISPR-Cas9 targeted enrichment and SMRT sequencing of repeat-expansion disease causative genomic regions
EP2663655B1 (en) Paired end random sequence based genotyping
US20230028445A1 (en) Identification of genomic structural variants using long-read sequencing
Tost et al. Molecular haplotyping at high throughput
WO2018144217A1 (en) Methods and compositions for enrichment of target polynucleotides
Wallace et al. CaBagE: A Ca s9-based Ba ck g round E limination strategy for targeted, long-read DNA sequencing
CN111893576B (zh) 一种微量细胞基因组测序文库构建方法
US20180355380A1 (en) Methods and kits for quality control
Løvendorf et al. Knockdown of circular RNAs using LNA-modified antisense oligonucleotides
Rajaram et al. Development of super-specific epigenome editing by targeted allele-specific DNA methylation
Fang et al. Haplotyping SNPs for allele-specific gene editing of the expanded huntingtin allele using long-read sequencing
JP7579817B2 (ja) Crisprで導入された二本鎖dna切断修復の同定、特徴付けおよび定量化
US20180346963A1 (en) Preparation of Concatenated Polynucleotides
Cheong et al. Diverse DNA methylation statuses at alternative promoters of human genes in various tissues
Tsai et al. Multiplex CRISPR/Cas9-Guided No-Amp targeted sequencing panel for spinocerebellar ataxia repeat expansions